These findings revealed the utility of DGKZ for prognostic stratification of patients with breast cancer and confirmed our hypothesis that DGKZ promotes the metastasis of human triple-negative breast cancer by activating SMAD-dependent TGFβ signaling. Here, DGKZ is linked to triple-negative breast carcinoma.